"Designing Growth Strategies is in our DNA"
Lung cancer, is a type of cancer disorder that originates in the lungs, the organs which are vital for the normal respiration of an individual. Lung cancer is now a leading cause of cancer deaths worldwide. The causes of lung cancer include the familial history of lung cancer, smoking, inhalation of secondhand smoke, and exposure to radon, asbestos, and other carcinogens. The symptoms of lung cancer include persistent coughs, chest pains, unexplained weight loss, and headaches.
Lung cancer often gives rise to other complications such as shortness of breath, pleural effusion, pain, coughing up of blood, and spread of cancer to other parts of the body. Several factors are considered while developing the treatment plan, which can include surgical procedures, radiation therapy, chemotherapy, targeted drug therapy, and immunotherapy. According to American Cancer Society estimates for lung cancer in 2019, 228,150 new cases are expected to record in the U.S leading to faster growth of the lung cancer screening market.
To gain extensive insights into the market, Request for Customization
The global lung cancer screening market is anticipated to grow faster, owing to increased prevalence of lung cancer, development in detection of lung cancer-specific biomarker, high smoking rates in the population, increased exposure to toxins, and good prognosis rates in early detection.
According to the estimates of the American Cancer Society (ACS), in 2018, 234,030 new cases of lung cancer were diagnosed in the U.S. These trends combined with other factors are expected to drive the lung cancer screening market positively.
However, the factor limiting the growth of global lung cancer screening market is high costs associated with certain screenings such as molecular diagnostics.
Some of the major companies present in the global lung cancer screening market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Abbott, QIAGEN, AstraZeneca, Agilent Technologies, Inc., Janssen Pharmaceuticals, Inc., Sanofi, Illumina Inc., and Others.
By Cancer Type
· Non-Small Cell Lung Cancer
· Small Cell Lung Cancer
By Diagnosis Type
· Low-Dose Spiral CT Scan
· Chest X-Ray
· Sputum Cytology
By End User
· Oncology Clinics
· Diagnostics Centers
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Among the segmentation of the global lung cancer screening market, non-small cell lung cancer in the cancer type segment holds a larger share owing to its high prevalence among the cancer types. This also is attributed to the significant growth of the lung cancer screening market during the forecast period.
Geographically, the global lung cancer screening market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global lung cancer screening market owing to a large proportion of smokers in the population, established healthcare system, high medical expenditure, access to advanced treatment options, demand for preventive care by diagnostic examinations, increasing geriatric population and rising awareness of lung cancer. The Asia Pacific is the fastest emerging market owing to increasing incidences of lung cancer, large population pools, and increased demand for advanced screening options.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry